First-in-human microdose trial of RDEA 427
Phase of Trial: Phase 0
Latest Information Update: 22 May 2008
At a glance
- Drugs RDEA 427 (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 22 May 2008 Status changed from in progress to completed according to Ardea Biosciences media release.
- 02 Apr 2008 New trial record.